September 3, 2026 C-Path Mourns the Passing of Board Member Peter Barton Hutt TUCSON, Ariz., September 3, 2026 — Critical Path Institute® (C-Path) is deeply saddened to announce the passing of Peter...
August 25, 2026 Critical Path for Parkinson’s Announces Milestone Publication Highlighting FDA Support for Novel Biomarker to Advance Precision Medicine Strategies TUCSON, Ariz., August 25, 2026 — Critical Path Institute® (C-Path) today announced the publication of "Regulatory...
August 20, 2026 C-Path Achieves Internationally Recognized Certification for Information Security Management C-Path) today announced it has achieved certification to ISO/IEC 27001:2022, the internationally...
August 18, 2026 C-Path Receives FDA Qualification for Rheumatoid Arthritis Fatigue Measure TUCSON, Ariz., August 18, 2026 — Critical Path Institute’s® (C-Path) Patient-Centered Evidence Consortium today announced...
August 6, 2026 C-Path’s Duchenne Consortium Awarded a $1.9 Million DoD Grant to Advance Understanding of Cardiomyopathy in Duchenne Muscular Dystrophy TUCSON, Ariz. August 6, 2026 — Critical Path Institute® (C-Path) today announced it has been awarded a grant in the amount...
July 21, 2026 Across Healthcare Matrix Partners with C-Path to Expand Rare Disease Data Platform Through Direct Integration TUCSON, Ariz., July 21, 2026 — Critical Path Institute (C-Path), a nonprofit that builds data and analytics tools to speed drug.
July 16, 2026 Crown Bioscience Joins C-Path’s New Approach Methodologies Developer Coalition TUCSON, Ariz., July 16, 2026 — Critical Path Institute's® (C-Path) New Approach Methodologies Developer Coalition...
July 14, 2026 Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) today announced that its Board of Directors has elected...
July 9, 2026 C-Path Awards $250,000 Grant to Advance New Treatment for Sepsis-Associated Neurocognitive Dysfunction TUCSON, Ariz., July 9, 2026 — Critical Path Institute® (C-Path) has awarded a $250,000 research grant to Teresa Sanchez, Ph.D.,
June 15, 2026 C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes TUCSON, Ariz., June 15, 2026 — Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today...